BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26558256)

  • 1. A Clinical Picture of the Visual Outcome in Adamantiades-Behçet's Disease.
    Figus M; Posarelli C; Albert TG; Talarico R; Nardi M
    Biomed Res Int; 2015; 2015():120519. PubMed ID: 26558256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye and Behçet's disease.
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Apr; 42(4):e133-e146. PubMed ID: 30850197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.
    Çakar Özdal P
    Turk J Ophthalmol; 2020 Jun; 50(3):169-182. PubMed ID: 32631005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eye and Behçet's disease].
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Jun; 42(6):626-641. PubMed ID: 31164292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ocular manifestations in Behçet's disease].
    Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
    Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular Involvement of Behçet's Syndrome: a Comprehensive Review.
    Ozyazgan Y; Ucar D; Hatemi G; Yazici Y
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):298-306. PubMed ID: 24828904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Manifestations in Late Onset Behçet's Disease.
    Saadouli D; Mansour KB; Yahyaoui S; Afrit NE; Lahmar A; Afrit AE
    Curr Aging Sci; 2021; 14(1):56-61. PubMed ID: 31994475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of Behçet's disease in the Indian population.
    Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
    Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular manifestations of Behçet's disease].
    Saadouli D; Lahmar A; Ben Mansour K; El Afrit N; Yahyaoui S; El Afrit MA
    J Fr Ophtalmol; 2021 Feb; 44(2):196-202. PubMed ID: 33380351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behçet disease: visual prognosis and factors influencing the development of visual loss.
    Taylor SR; Singh J; Menezo V; Wakefield D; McCluskey P; Lightman S
    Am J Ophthalmol; 2011 Dec; 152(6):1059-66. PubMed ID: 21872204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular involvement in Behçet's disease.
    Peplinski LS
    J Am Optom Assoc; 1989 Nov; 60(11):854-7. PubMed ID: 2607080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment.
    Deuter CM; Kötter I; Günaydin I; Zierhut M; Stübiger N
    Adv Exp Med Biol; 2003; 528():525-8. PubMed ID: 12918756
    [No Abstract]   [Full Text] [Related]  

  • 13. Adamantiades-Behcet disease: diagnosis and current concepts in management of ocular manifestations.
    Durrani K; Ahmed M; Foster CS
    Compr Ophthalmol Update; 2007; 8(4):225-33. PubMed ID: 17999836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.
    Davatchi F; Shahram F; Chams H; Jamshidi AR; Nadji A; Chams C; Akbarian M; Gharibdoost F
    Adv Exp Med Biol; 2003; 528():579-84. PubMed ID: 12918769
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Behçet's disease yesterday and today].
    Deuter CM; Zierhut M; Doycheva D; Kötter I
    Ophthalmologe; 2012 Jun; 109(6):568-74. PubMed ID: 22699948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
    Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
    J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
    Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
    Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
    Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
    Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adamantiades-Behcet's disease-complicated gastroenteropathy.
    Wu QJ; Zhang FC; Zhang X
    World J Gastroenterol; 2012 Feb; 18(7):609-15. PubMed ID: 22363131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G; Jovanović S; Veselinović D; Zivković M
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.